EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
28 11-2023

Alzheimer’s and Parkinson’s Diseases Conference

2023-11-28T14:12:48+00:0028-11-2023|

The Alzheimer's and Parkinson's Diseases Conference (AD/PD™) will take place on 5-9 March 2024 in Lisbon (Portugal) and virtually. The AD/PD™ Conference is where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer's and Parkinson's. From uncovering groundbreaking discoveries to sharing the latest developments in treatments. The Conference [...]

13 10-2023

Defeating Dementia Conference | Event highlights

2023-10-18T08:22:54+00:0013-10-2023|News|

EBC was honoured to be part of the Defeating Dementia Conference, bringing together leading experts in dementia, which took place on 2 October 2023 in The Hague. The event was organised by the Ministry of Health, Welfare and Sport of The Netherlands in collaboration with the World Dementia Council. Representatives from G20 governments, international institutions, [...]

9 10-2023

Look back at the highlights of the Rethinking Alzheimer’s disease virtual event

2023-10-09T09:28:30+00:0009-10-2023|News|

Alzheimer's disease, the most common form of dementia, is a pressing issue for our lifetime. Society needs to be responsive to ensure that people can live with more dignity and access services and resources despite their diagnosis. On 26 September 2023, the European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical [...]

25 07-2023

Registration now open for the Rethinking Alzheimer’s disease virtual event

2023-09-06T14:45:31+00:0025-07-2023|News|

Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association [...]

13 06-2023

Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden

2023-09-01T15:04:14+00:0013-06-2023|

Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden, taking place virtually on 26 September 2023 at 09:00 – 11:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Swedish Brain Foundation (SBF) and the Swedish Association of [...]

3 04-2023

EAN Congress: Rethinking the management of brain disorders: Alzheimer’s disease & migraine

2023-04-03T13:41:16+00:0003-04-2023|

The European Brain Council (EBC) is pleased to hold a Scientific Theatre on "Rethinking the management of brain disorders: Alzheimer's disease & migraine" on 1 July 20223 at 11:00 - 11:30 during the 9th Annual Congress of the European Academy of Neurology in Budapest (Hungary). Despite improvements and innovation in recent years, [...]

14 03-2023

EBC & EFPIA launch RETHINKING Alzheimer’s disease White Paper

2023-04-03T14:57:28+00:0014-03-2023|News|

On the occasion of the Brain Awareness Week, the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) launch the RETHINKING Alzheimer's disease White Paper, calling for change in the detection and diagnosis of Alzheimer's disease. About Alzheimer's disease Alzheimer’s disease (AD), the most common form of [...]

24 01-2023

EBC & EFPIA hold RETHINKING Alzheimer’s event ahead of policy paper launch

2023-03-30T09:01:01+00:0024-01-2023|News|

Every three seconds someone develops dementia and for most of these individuals this will be as a result of Alzheimer’s disease, the leading cause. Alzheimer's is a relentless neurodegenerative condition which robs people of their memories, their independence, their relationships, and ultimately, their lives. On 24 January 2023, the European Brain Council (EBC), in collaboration [...]

8 12-2022

Registration now open for the launch event of the RETHINKING Alzheimer’s disease White Paper

2023-01-10T12:03:16+00:0008-12-2022|News|

Registration is now open for the launch event of the RETHINKING Alzheimer's disease White Paper, taking place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper [...]

24 11-2022

Save the date for the launch event of the RETHINKING Alzheimer’s disease White Paper!

2023-01-10T13:12:36+00:0024-11-2022|News|

The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]

Go to Top